Vertex Pharmaceuticals (VRTX) Goodwill (2009 - 2026)

Vertex Pharmaceuticals' Goodwill history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Goodwill changed 0.0% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (changed 0.0% YoY), while the FY2025 annual figure was $1.1 billion, changed 0.0% from the prior year.
• Goodwill for Q1 2026 stood at $1.1 billion, roughly flat from $1.1 billion in the prior quarter.
• The five-year high for Goodwill was $1.1 billion in Q4 2023, with the low at $1.0 billion in Q1 2022.
• The 5-year median for Goodwill is $1.1 billion (2022), against an average of $1.1 billion.
• The sharpest annual moves came in 2022 and 2024: Goodwill grew 8.8% in 2022, then dropped 1.09% in 2024.
• Vertex Pharmaceuticals' Goodwill stood at $1.1 billion in 2022, then rose by 1.1% to $1.1 billion in 2023, then fell by 1.09% to $1.1 billion in 2024, then changed by 0.0% to $1.1 billion in 2025, then changed by 0.0% to $1.1 billion in 2026.
• Business Quant data shows VRTX's Goodwill at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.